Home>
US Stocks>
Molecular Partners Ag -adr

Molecular Partners Ag -adr share price today

(MOLN)

Molecular Partners Ag -adr share price is $5.08 & ₹431.68 as on 21 Dec 2024, 2.30 'hrs' IST

$5.08

▲

-0.14

(-2.68%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Molecular Partners Ag -adr share price in Dollar and Rupees. Guide to invest in Molecular Partners Ag -adr from India. Also see the sentimental analysis on Indian investors investing in Molecular Partners Ag -adr. Get details on the Indian mutual funds that are investing in Molecular Partners Ag -adr. Get Analyst recommendations and forecasts along with all the Molecular Partners Ag -adr's financials.

Molecular Partners Ag -adr share price movements

Today's Low: $5.08
Today's High: $5.19
$5.08
0.0%
Downside
Day's Volatility :2.12%
Upside
2.12%
52 Weeks Low: $3.32
52 Weeks High: $12.70
$5.08
34.65%
Downside
52 Weeks Volatility :73.86%
Upside
60.0%

Molecular Partners Ag -adr Returns

Period	Molecular Partners Ag -adr	Sector (Health Care)	Index (Russel 2000)
3 Months	7.4%	-11.1%	0.0%
6 Months	-29.35%	-6.0%	0.0%
1 Year	11.16%	2.7%	0.0%
3 Years	-74.16%	0.6%	-19.7%

Molecular Partners Ag -adr Key Statistics

in dollars & INR

Previous Close	$5.22
Open	$5.19
Today's High	$5.19
Today's Low	$5.08
Market Capitalization	$192.4M
Today's Volume	$15.0K
52 Week High	$12.7
52 Week Low	$3.32
Revenue TTM	$6.0M
EBITDA	$-62.2M
Earnings Per Share (EPS)	$-2.12
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.37%

How to invest in Molecular Partners Ag -adr from India?

It is very easy for Indian residents to invest directly in Molecular Partners Ag -adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Molecular Partners Ag -adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Molecular Partners Ag -adr or MOLN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Molecular Partners Ag -adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Molecular Partners Ag -adr shares which would translate to 0.167 fractional shares of Molecular Partners Ag -adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Molecular Partners Ag -adr, in just a few clicks!

Returns in Molecular Partners Ag -adr for Indian investors in Rupees

Investment Value

₹1,00,000

Molecular Partners Ag -adr investment value today

Current value as on today

₹1,13,356

Returns

₹13,356

(+13.36%)

Returns from Molecular Partners Ag -adr Stock

₹11,160 (+11.16%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Molecular Partners Ag -adr

-46%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Molecular Partners Ag -adr on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -46% less investors are searching Molecular Partners Ag -adr in the last 30 days versus the previous period.

Global Institutional Holdings in Molecular Partners Ag -adr

Bvf Inc
1.20%
Suvretta Capital Management, LLC
1.09%
UBS Group AG
0.01%

Analyst Recommendation on Molecular Partners Ag -adr

Sell

9%Buy

27%Hold

63%Sell

Based on 11 Wall street analysts offering stock ratings for Molecular Partners Ag -adr(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Molecular Partners Ag -adr

What analysts predicted

Upside of 104.44%

Current:

$5.08

Target:

$10.39

Insights on Molecular Partners Ag -adr

Price Movement
In the last 6 months, MOLN stock has moved down by -47.1%
Decreasing Revenue
Revenue is down for the last 3 quarters, 2.73M → 681.0K (in $), with an average decrease of 49.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -11.32M → -16.40M (in $), with an average decrease of 21.0% per quarter
MOLN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 22.1%
MOLN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 97.5%
Price to Sales
ForMOLN every $1 of sales, investors are willing to pay $27.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Molecular Partners Ag -adr Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$10.4M	↓ 48.27%
Net Income	$-37.3M	↑ 45.64%
Net Profit Margin	-357.66%	↓ 230.61%

	FY19	Y/Y Change
Revenue	$20.7M	↑ 96.84%
Net Income	$-36.9M	↓ 2.02%
Net Profit Margin	-178.03%	↑ 179.63%

	FY20	Y/Y Change
Revenue	$10.5M	↓ 54.16%
Net Income	$-70.6M	↑ 72.96%
Net Profit Margin	-671.7%	↓ 493.67%

	FY21	Y/Y Change
Revenue	$10.1M	↓ 0.15%
Net Income	$-69.3M	↑ 1.63%
Net Profit Margin	-683.65%	↓ 11.95%

	FY22	Y/Y Change
Revenue	$203.1M	↑ 1931.68%
Net Income	$126.3M	↓ 284.77%
Net Profit Margin	62.17%	↑ 745.82%

	FY23	Y/Y Change
Revenue	$8.1M	↓ 96.29%
Net Income	$-71.7M	↓ 152.59%
Net Profit Margin	-880.7%	↓ 942.87%

	Q2 FY23	Q/Q Change
Revenue	$460.9K	↓ 86.39%
Net Income	$-17.8M	↑ 4.33%
Net Profit Margin	-3.9K%	↓ 3349.9%

	Q3 FY23	Q/Q Change
Revenue	$2.8M	↑ 512.29%
Net Income	$-12.7M	↓ 28.45%
Net Profit Margin	-450.18%	↑ 3402.11%

	Q4 FY23	Q/Q Change
Revenue	$1.2M	↓ 59.39%
Net Income	$-22.9M	↑ 72.92%
Net Profit Margin	-1.9K%	↓ 1466.49%

	Q1 FY24	Q/Q Change
Revenue	$3.1M	↑ 165.31%
Net Income	$-12.7M	↓ 42.75%
Net Profit Margin	-413.62%	↑ 1503.05%

	Q2 FY24	Q/Q Change
Revenue	$1.7M	↓ 43.35%
Net Income	$-16.9M	↑ 33.17%
Net Profit Margin	-972.4%	↓ 558.78%

	Q3 FY24	Q/Q Change
Revenue	$681.0K	↓ 56.09%
Net Income	$-16.4M	↑ 8.77%
Net Profit Margin	-2.4K%	↓ 1436.41%

	FY18	Y/Y Change
Profit	$-5.3M	↓ 339.15%

	FY19	Y/Y Change
Profit	$-23.5M	↑ 340.54%

	FY20	Y/Y Change
Profit	$-52.6M	↑ 102.17%

	FY21	Y/Y Change
Profit	$-50.4M	↓ 0.73%

	FY22	Y/Y Change
Profit	$148.7M	↓ 399.23%

	FY23	Y/Y Change
Profit	$-47.2M	↓ 129.4%

	Q2 FY23	Q/Q Change
Profit	$-12.5M	↑ 16.3%

	Q3 FY23	Q/Q Change
Profit	$-10.1M	↓ 19.18%

	Q4 FY23	Q/Q Change
Profit	$-12.6M	↑ 19.99%

	Q1 FY24	Q/Q Change
Profit	$-12.8M	↑ 4.49%

	Q2 FY24	Q/Q Change
Profit	$-12.9M	↑ 1.5%

	Q3 FY24	Q/Q Change
Profit	$681.0K	↓ 105.9%

	FY18	Y/Y Change
Operating Cash Flow	$-42.8M	↑ 6.13%
Investing Cash Flow	$9.7M	↓ 53.93%
Financing Cash Flow	$395.1K	↓ 50.94%

	FY19	Y/Y Change
Operating Cash Flow	$-1.2M	↓ 97.2%
Investing Cash Flow	$-20.2M	↓ 306.35%
Financing Cash Flow	$-230.9K	↓ 157.91%

	FY20	Y/Y Change
Operating Cash Flow	$-32.6M	↑ 2337.59%
Investing Cash Flow	$-24.5M	↑ 9.63%
Financing Cash Flow	$127.3M	↓ 49968.72%

	FY21	Y/Y Change
Operating Cash Flow	$-98.8M	↑ 213.81%
Investing Cash Flow	$-24.2M	↑ 2.26%
Financing Cash Flow	$54.9M	↓ 55.32%

	FY22	Y/Y Change
Operating Cash Flow	$127.1M	↓ 230.36%
Investing Cash Flow	$-108.4M	↑ 354.74%
Financing Cash Flow	$-1.7M	↓ 103.1%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-14.7M	↓ 19.72%
Investing Cash Flow	$4.5M	↑ 0.0%
Financing Cash Flow	$-304.3K	↓ 7.74%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-14.7M	↓ 0.67%
Investing Cash Flow	$19.8M	↑ 340.5%
Financing Cash Flow	$-331.6K	↑ 8.76%

Molecular Partners Ag -adr Technicals Summary

Sell

Neutral

Buy

Molecular Partners Ag -adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Molecular Partners Ag -adr Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Molecular Partners Ag -adr	-6.27%	-29.35%	11.16%	-74.16%	-73.36%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Molecular Partners Ag -adr	1.71	NA	NA	-1.6	-0.37	-0.21	NA	4.18
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Molecular Partners Ag -adr	Sell	$192.4M	-73.36%	1.71	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Molecular Partners Ag -adr

Organization	Molecular Partners Ag -adr
Employees	167
CEO	Dr. Patrick Amstutz Ph.D.
Industry	Services

Management People of Molecular Partners Ag -adr

Name	Title
Dr. Patrick Amstutz Ph.D.	Co-Founder, CEO, Member of Management Board & Director
Dr. Michael Tobias Stumpp Ph.D.	Co-Founder, Executive VP of Projects & Member of Management Board
Mr. Robert Hendriks	Senior VP of Finance
Mr. Alexander Zurcher	COO & Member of Management Board
Ms. Renate Gloggner	Executive VP of People & Community and Member of Management Board
Mr. Daniel Steiner Ph.D.	Senior Vice President of Research & Technology
Mr. Seth D. Lewis	Senior Vice President of Investor Relations, Communications & Strategy
Mr. Michael Pitzner	General Counsel, Compliance Officer, Senior VP Legal & Business Development
Dr. Pamela A. Trail Ph.D.	Strategic Consultant
Ms. Anne Goubier D.V.M., Ph.D.	Senior Vice President of Research & Early Development

Important FAQs about investing in Molecular Partners Ag -adr from India :

What is Molecular Partners Ag -adr share price today?

Molecular Partners Ag -adr share price today stands at $5.08, Open: $5.19 ; Previous Close: $5.22 ; High: $5.19 ; Low: $5.08 ; 52 Week High: $12.70 ; 52 Week Low: $3.32. The stock opens at $5.19, after a previous close of $5.22. The stock reached a daily high of $5.19 and a low of $5.08, with a 52-week high of $12.70 and a 52-week low of $3.32.

Can Indians buy Molecular Partners Ag -adr shares?

Yes, Indians can invest in the Molecular Partners Ag -adr (MOLN) from India.

With INDmoney, you can buy Molecular Partners Ag -adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Molecular Partners Ag -adr at zero transaction cost.

How can I buy Molecular Partners Ag -adr shares from India?

It is very easy to buy Molecular Partners Ag -adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Molecular Partners Ag -adr be purchased?

Yes, you can buy fractional shares of Molecular Partners Ag -adr with INDmoney app.

What are the documents required to start investing in Molecular Partners Ag -adr stocks?

To start investing in Molecular Partners Ag -adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.